Arzerra and Sepsis - a phase IV clinical study of FDA data

Summary:

Sepsis is reported as a side effect among people who take Arzerra (ofatumumab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Zofran, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Sepsis when taking Arzerra. It is created by eHealthMe based on reports of 1,041 people who have side effects when taking Arzerra from the FDA, and is updated regularly.

What is Arzerra?

Arzerra has active ingredients of ofatumumab. eHealthMe is studying from 1,042 Arzerra users. Check the latest studies of Arzerra.

What is Sepsis?

Sepsis (a severe blood infection that can lead to organ failure and death) is found to be associated with 2,522 drugs and 3,259 conditions by eHealthMe. Check the latest studies of Sepsis.

On Jul, 17, 2026

1,041 people reported to have side effects when taking Arzerra.
Among them, 26 people (2.5%) have Sepsis.

Among these 26 people:

How long have people been on Arzerra when they have Sepsis? *

What is the gender of people who have Sepsis when taking Arzerra? *

female: 19.05 %
male: 80.95 %

What is the age of people who have Sepsis when taking Arzerra? *

What are other drugs people take besides Arzerra? *

Zofran: 5 people, 19.23%
Hydrocodone: 4 people, 15.38%
Cotrim: 2 people, 7.69%
Lopressor: 2 people, 7.69%
Melatonin: 2 people, 7.69%
Methimazole: 2 people, 7.69%
Mirapex: 2 people, 7.69%
Diltiazem Hydrochloride: 2 people, 7.69%
Cymbalta: 2 people, 7.69%
Myrbetriq: 2 people, 7.69%

What are other side effects people have besides Sepsis? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 26.92%
Fever: 7 people, 26.92%
Thrombocytopenia (decrease of platelets in blood): 6 people, 23.08%
Anaemia (lack of blood): 5 people, 19.23%
Pneumonia: 4 people, 15.38%
Febrile Neutropenia (fever with reduced white blood cells): 4 people, 15.38%
Multi-Organ Failure (multisystem organ failure): 3 people, 11.54%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 11.54%
Diarrhea: 3 people, 11.54%
Dyspnea Exertional: 3 people, 11.54%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 17 people, 65.38%
Pain: 3 people, 11.54%
Lymphoma (cancer that begins in immune system cells): 3 people, 11.54%
Rashes (redness): 2 people, 7.69%
Parkinson's Disease: 2 people, 7.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 7.69%
High Blood Cholesterol: 2 people, 7.69%
White Blood Cell Count Increased: 1 person, 3.85%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 3.85%
Red Blood Cell Count Decreased: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Arzerra and have Sepsis?

- Check whether Sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Arzerra:

Arzerra (1,042 reports)

Sepsis treatments and more:

Sepsis (140,102 reports)

Browse all side effects of Arzerra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sepsis:

Sepsis (2,522 drugs)

Browse all the conditions that are associated with Sepsis:

Sepsis (3,259 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ofatumumab (the active ingredients of Arzerra) and Arzerra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.